Givaudan | GIVN - Loan Capital


Givaudan reported CHF4.19B in Loan Capital for its fiscal semester ending in December of 2025.





Loan Capital Change Date
Air Liquide EUR 12.24B 1.17B Jun/2026
Akzo Nobel EUR 5.5B 743M Jun/2026
Anheuser-Busch USD 68.91B 1.44B Jun/2026
Arkema EUR 2.91B 902.9M Jun/2026
Associated British Foods GBP 3.14B 164M Dec/2025
BASF EUR 18.83B 1.08B Jun/2026
Bayer EUR 30.68B 1.15B Mar/2026
Beiersdorf EUR 117M 15M Dec/2025
British American Tobacco GBP 31.04B 663M Jun/2026
Covestro EUR 1.67B 408M Dec/2025
Croda International GBP 650.9M 22.1M Dec/2024
Danone EUR 10.68B 609M Jun/2026
Diageo GBP 19.06B 1.83B Jun/2026
Fresenius EUR 9.55B 1.24B Jun/2026
Fresenius Medical Care EUR 5.74B 895.27M Mar/2026
Givaudan CHF 4.19B 448M Dec/2025
Heineken EUR 4.35B 11.84B Jun/2026
Henkel EUR 3.26B 1.88B Jun/2026
International Flavors Fragrances USD 4.74B 4M Jun/2026
Johnson Matthey GBP 1.35B 2M Jun/2026
Kerry EUR 2.78B 297.5M Jun/2026
Lonza CHF 3.88B 323M Dec/2025
L'Oréal EUR 11.72B 2.29B Jun/2026
Merck EUR 10.8B 72M Mar/2026
Nestle CHF 46.5B 254M Jun/2026
Pernod Ricard EUR 11.93B 1.15B Dec/2025
Reckitt Benckiser GBP 7.24B 590M Dec/2024
SGS CHF 3.11B 380M Dec/2024
Sika AG CHF 4.13B 1.4B Dec/2025
Solvay EUR 1.82B 11M Jun/2026
Tate & Lyle GBP 1.27B 141M Jun/2026
Umicore EUR 2.36B 113.6M Jun/2026
Victrex GBP 37.1M 7.5M Jun/2026